Chao Liu

Dr. Chao Liu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LMLan Ma
Lan Ma
YYYijun Yu
Yijun Yu
HLHanxiao Liu
Hanxiao Liu
WSWeibin Sun
Weibin Sun
ZLZitong Lin
Zitong Lin
LMLeiying Miao
Leiying Miao
The repair of skeletal defects in maxillofacial region remains an intractable problem, the rising technology of bone tissue engineering provides a new strategy to solve it. Scaffolds, a crucial element of tissue engineering, must have favorable biocompatibility as well as osteoinductivity. In this study, we prepared berberine/polycaprolactone/collagen (BBR/PCL/COL) scaffolds with different concentrations of berberine (BBR) (25, 50, 75 and 100 μg/mL) through electrospinning. The influence of dosage on scaffold morphology, cell behavior and in vivo bone defect repair were systematically studied. The results indicated that scaffolds could release BBR stably for up to 27 days. Experiments in vitro showed that BBR/PCL/COL scaffolds had appropriate biocompatibility in the concentration of 25–75 μg/mL, and 50 and 75 μg/mL scaffolds could significantly promote osteogenic differentiation of dental pulp stem cells. Scaffold with 50 μg/mL BBR was implanted into the critical bone defect of rats to evaluate the ability of bone repair in vivo. It was found that BBR/PCL/COL scaffold performed more favorable than polycaprolactone/collagen (PCL/COL) scaffold. Overall, our study is the first to evaluate the capability of in vivo bone repair of BBR/PCL/COL electrospun scaffold. The results indicate that BBR/PCL/COL scaffold has prospective potential for tissue engineering applications in bone regeneration therapy.

4 September 2018 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SRShuangshuang Ren
Shuangshuang Ren
JYJie Yang
Jie Yang
LMLan Ma
Lan Ma
XLXincong Li
Xincong Li
WWWenlei Wu
Wenlei Wu
LMLeiying Miao
Leiying Miao

3 February 2023 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
LXLiping Xiong
Liping Xiong
HBHan Bao
Han Bao
SLSize Li
Size Li
DGDeao Gu
Deao Gu
YLYuyang Li
Yuyang Li
CLChao Liu
Chao Liu
Graphical In TMJ-OA, CNPs could effectively remove ROS in chondrocytes by activating the Nrf2/HO-1 signaling pathway and exert excellent antioxidant and anti-inflammatory effects.

18 December 2019 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Open access
YYYijun Yu
Yijun Yu
LMLan Ma
Lan Ma
HZHe Zhang
He Zhang
WSWeibin Sun
Weibin Sun
LZLichun Zheng
Lichun Zheng
LMLeiying Miao
Leiying Miao
Bone defects caused by many factors prompt further study of pathological process and restoration methods. This study was aimed to clarify the effect of erythropoietin on the repair of bone defect. We added the designated concentration of rhEPO to endothelial progenitor cells and marrow stromal cells, then detected its osteogenic and angiogenesis effects. The results showed that rhEPO promoted the proliferation of EPC and ST2 by promoting the mitosis without affecting cell apoptosis. The protein and mRNA levels of angiogenesis and osteogenic related factors exhibited higher expressions. Additionally, rhEPO encapsulated in PLGA scaffolds accelerated the new bone formation in rat calvaria bone defect model. Since the centre of bone defect was hypoxia environment, we cultured EPC and ST2 under hypoxia. SiRNA and an inhibitor of HIF-1 were used to interfere HIF-1, then the following changes of VEGF and EPO were detected. The results showed that all the factors were upregulated under the hypoxia environment. The expression of VEGF at protein and mRNA level decreased as HIF-1 was inhibited or interfered from 6 h, while the mRNA expression of EPO from 6 h and changed significantly at protein level from 12 h. Therefore, EPO is a promising factor for further studies.

15 December 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
XLXincong Li
Xincong Li
YZYue Zhao
Yue Zhao
HPHaoran Peng
Haoran Peng
DGDeao Gu
Deao Gu
CLChao Liu
Chao Liu
LMLeiying Miao
Leiying Miao
Graphical We introduce novel mitophagy enhancer, MitoQ@PssL NPs exert excellently anti-inflammatory effects by activating mitophagy and clearing partial mitochondrial ROS, thereby accelarating osteogenesis in periodontitis.

9 December 2023 in Materials Today Bio
Verified
Journal Article
Open access
YZYue Zhao
Yue Zhao
LSLutong Song
Lutong Song
MLMengchen Li
Mengchen Li
HPHaoran Peng
Haoran Peng
XQXinyi Qiu
Xinyi Qiu
LMLeiying Miao
Leiying Miao
Vital pulp preservation, which is a clinical challenge of aseptic or iatrogenic accidental exposure of the pulp, in cases direct pulp capping is the main technology. Human dental pulp stem cells (hDPSCs) play a critical role in pulp tissue repair, but their differentiative ability could be inhibited by the potential infection and inflammatory response of the exposed pulp. Therefore, inflammatory regulation and differentiated promotion of hDPSCs are both essential for preserving living pulp teeth. In this study, we constructed a functional dental pulp-capping hydrogel by loading cerium oxide nanoparticles (CNPs) and dentin matrix protein-1 (DMP1) into an injectable Fmoc–triphenylalanine hydrogel (Fmoc-phe3 hydrogel) as CNPs/DMP1/Hydrogel for in situ drugs delivery. With a view to long-term storage and release of CNPs (anti-inflammatory and antioxidant) to regulate the local inflammatory environment and DMP1 to promote the regeneration of dentin. Results of CCK-8, LDH release, hemolysis, and Live/Dead assessment of cells demonstrated the good biocompatibility of CNPs/DMP1/Hydrogel. The levels of alkaline phosphatase activity, quantification of the mineralized nodules, expressions of osteogenic genes and proteins demonstrated CNPs/DMP1/Hydrogel could protect the activity of hDPSCs’ osteogenic/dentinogenic differentiation by reducing the inflammation response via releasing CNPs. The therapy effects were further confirmed in rat models, CNPs/DMP1/Hydrogel reduced the necrosis rate of damaged pulp and promoted injured pulp repair and reparative dentin formation with preserved vital pulps. In summary, the CNPs/DMP1/Hydrogel composite is an up-and-coming pulp-capping material candidate to induce reparative dentin formation, as well as provide a theoretical and experimental basis for developing pulp-capping materials.